Page last updated: 2024-10-22

alendronate and Erythema

alendronate has been researched along with Erythema in 2 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.

Research Excerpts

ExcerptRelevanceReference
"Alendronate is a bisphosphonate compound used to treat diseases of pathologic bone resorption."5.32Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis. ( Cockerell, CJ; Cohen, JB; High, WA; Wetherington, W, 2003)
"Alendronate is a bisphosphonate compound used to treat diseases of pathologic bone resorption."1.32Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis. ( Cockerell, CJ; Cohen, JB; High, WA; Wetherington, W, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Villanueva-Martínez, A1
Hernández-Rizo, L1
Ganem-Rondero, A1
High, WA1
Cohen, JB1
Wetherington, W1
Cockerell, CJ1

Other Studies

2 other studies available for alendronate and Erythema

ArticleYear
Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate.
    International journal of pharmaceutics, 2020, May-30, Volume: 582

    Topics: Administration, Cutaneous; Alendronate; Animals; Bone Density Conservation Agents; Drug Carriers; Dr

2020
Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis.
    Journal of the American Academy of Dermatology, 2003, Volume: 48, Issue:6

    Topics: Aged; Alendronate; Erythema; Female; Humans; Osteoporosis

2003